The fact
FDA procedure delays fuel uncertainty about drug candidate commercialization timelines.
Low trading volume underscores doubt surrounding the company's therapeutic pipeline.
Click the link to read an article on the topic:
FDA procedure delays fuel uncertainty about drug candidate commercialization timelines.
Low trading volume underscores doubt surrounding the company's therapeutic pipeline.